Rethinking Chronic Condition Management
Join us on Sept. 18 as we explore why obesity, diabetes, and cardiovascular disease still dominate employer health-plan costs—and how emerging GLP-1 therapies are redefining chronic care and weight management, promising healthier outcomes and reduce medical costs.